Criteria of Evidence to Move Potential Chemopreventive Agents into Late Phase Clinical Trials

E-ISSN： 1873-5592|12|13|1983-1988

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.13, 2011-12, pp. : 1983-1988

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comprehensive Review of Cancer Chemopreventive Agents Evaluated in Experimental Carcinogenesis Models and Clinical Trials

Current Medicinal Chemistry, Vol. 15, Iss. 11, 2008-05 ,pp. : 1044-1071

Bentham Science Publishers

Access to resources Recommend Favorite

Diterpenoids- Potential Chemopreventive and Chemotherapeutic Agents in Leukemia

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 2, 2014-02 ,pp. : 127-142

Bentham Science Publishers

Access to resources Recommend Favorite

Organoselenium Compounds as Potential Therapeutic and Chemopreventive Agents: A Review

Current Medicinal Chemistry, Vol. 11, Iss. 12, 2004-06 ,pp. : 1657-1669

Bentham Science Publishers

Access to resources Recommend Favorite

The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3853-3858

Blackwell Publishing

Access to resources Recommend Favorite

Cancer Preventive Agents. Part 6: Chemopreventive Potential of Furanocoumarins and Related Compounds

By Wang Xihong Nakagawa-Goto Kyoko Kozuka Mutsuo Tokuda Harukuni Nishino Hoyoku Lee Kuo-Hsiung

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 44, Iss. 2, 2006-03 ,pp. : 116-120

Informa Healthcare

Access to resources Recommend Favorite